CAMP
Camp4 Therapeutics Corp SEC filings
Every EDGAR filing for Camp4 Therapeutics Corp (CAMP), newest first, with AI summaries and stories.
- Ticker
- CAMP
- CIK
- 1736730
- Sector
- Biotech and pharma
- Latest filing
- Sep 28
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Filings
8-KCamp4 Therapeutics CorpCAMPLIVE 4Camp4 Therapeutics CorpCAMPLIVE Kelly Gold, insider filing for CAMP
Kelly Gold, reporting
SCHEDULE 13D/ACamp4 Therapeutics CorpCAMPLIVE Ownership stake disclosure by 5AM Ventures VI, L.P. (amended)
5AM Ventures VI, L.P., filed by
4Camp4 Therapeutics CorpCAMPLIVE Andrew J. Schwab, insider filing for CAMP
Andrew J. Schwab, reporting
4Camp4 Therapeutics CorpCAMPLIVE Andrew J. Schwab, insider filing for CAMP
Andrew J. Schwab, reporting
4Camp4 Therapeutics CorpCAMPLIVE Andrew J. Schwab, insider filing for CAMP
Andrew J. Schwab, reporting
4Camp4 Therapeutics CorpCAMPLIVE Daniel Tardiff, insider filing for CAMP
Daniel Tardiff, reporting
SCHEDULE 13D/ACamp4 Therapeutics CorpCAMPLIVE Ownership stake disclosure by Polaris Management Co. VII, L.L.C. (amended)
Polaris Management Co. VII, L.L.C., filed by
144Camp4 Therapeutics CorpCAMPLIVE Daniel Tardiff, planned sale of CAMP shares
Daniel Tardiff, reporting
SCHEDULE 13G/ACamp4 Therapeutics CorpCAMPLIVE Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P. (amended)
BALYASNY ASSET MANAGEMENT L.P., filed by
10-QCamp4 Therapeutics CorpCAMPLIVE 8-KCamp4 Therapeutics CorpCAMPLIVE EFFECTCamp4 Therapeutics CorpCAMPLIVE 424B3Camp4 Therapeutics CorpCAMPLIVE SCHEDULE 13GCamp4 Therapeutics CorpCAMPLIVE Ownership stake disclosure by Trails Edge Capital Partners, LP
Trails Edge Capital Partners, LP, filed by
S-3Camp4 Therapeutics CorpCAMPLIVE SCHEDULE 13D/ACamp4 Therapeutics CorpCAMPLIVE Ownership stake disclosure by 5AM Ventures VI, L.P. (amended)
5AM Ventures VI, L.P., filed by
4Camp4 Therapeutics CorpCAMPLIVE 6 insider filings
Kush Parmar, insider filing for CAMP
Show all 6
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
Kush Parmar, reporting · 5AM Ventures VI, L.P., reporting · +5 more
8-KCamp4 Therapeutics CorpCAMPLIVE 8-KCamp4 Therapeutics CorpCAMPLIVE 4Camp4 Therapeutics CorpCAMPLIVE 6 insider filings
Steven H Holtzman, insider filing for CAMP
Show all 6
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
Steven H Holtzman, reporting
8-KCamp4 Therapeutics CorpCAMPLIVE SCHEDULE 13GCamp4 Therapeutics CorpCAMPLIVE Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P., filed by
8-KCamp4 Therapeutics CorpCAMPLIVE 10-QCamp4 Therapeutics CorpCAMPLIVE 8-KCamp4 Therapeutics CorpCAMPLIVE ARSCamp4 Therapeutics CorpCAMPLIVE DEFA14ACamp4 Therapeutics CorpCAMPLIVE DEF 14ACamp4 Therapeutics CorpCAMPLIVE 4Camp4 Therapeutics CorpCAMPLIVE 6 insider filings
Daniel Tardiff, insider filing for CAMP
Show all 6
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 4Insider filing for CAMP
- 3New insider at CAMP
Daniel Tardiff, reporting
8-KCamp4 Therapeutics CorpCAMPLIVE SCHEDULE 13D/ACamp4 Therapeutics CorpCAMPLIVE Ownership stake disclosure by Enavate Sciences GP, LLC (amended)
Enavate Sciences GP, LLC, filed by
S-8Camp4 Therapeutics CorpCAMPLIVE 10-KCamp4 Therapeutics CorpCAMPLIVE 8-KCamp4 Therapeutics CorpCAMPLIVE